Gilead Bolsters Inflammatory Bowel Disease Pipeline With Promising Mid-Stage Trial Success

기사 요약

Gilead Sciences announced positive Phase 2 SWIFT trial results for emvistegrast, an oral treatment for active ulcerative colitis.